Kim Becker Ifantides, PharmD

Associate Director, Medical Affairs
AbbVie

Poster(s):

• 1334 - SYNCHRONIZE: Real-world retrospective safety analysis in patients treated with onabotulinumtoxinA for more than one therapeutic indication
  Friday, February 23, 2024

  5:00 PM – 6:30 PM EDT

• 1336 - Incidence of dysphagia and comorbidities in patients with cervical dystonia, analyzed by botulinum neurotoxin treatment exposure
  Friday, February 23, 2024

  5:00 PM – 6:30 PM EDT